Blonanserin

CAS No. 132810-10-7

Blonanserin( AD5423 | Lonasen )

Catalog No. M11308 CAS No. 132810-10-7

Blonanserin is a novel atypical antipsychotic agent with potent dopamine D2 and serotonin 5-HT2 receptors antagonist properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 28 In Stock
10MG 43 In Stock
25MG 77 In Stock
50MG 113 In Stock
100MG 158 In Stock
200MG 284 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Blonanserin
  • Note
    Research use only, not for human use.
  • Brief Description
    Blonanserin is a novel atypical antipsychotic agent with potent dopamine D2 and serotonin 5-HT2 receptors antagonist properties.
  • Description
    Blonanserin is a novel atypical antipsychotic agent with potent dopamine D2 and serotonin 5-HT2 receptors antagonist properties.(In Vitro):Blonanserin exerts some blockade of α1-adrenergic receptors (Ki=26.7 nM) and also shows significant affinity for the D3?receptor (Ki=0.494 nM). Blonanserin possesses low affinity for the sigma receptor (IC50=286 nM), but lacks significant affinity for numerous other sites including the 5-HT1A, 5-HT3, D1, α2-adrenergic, β-adrenergic, H1, and mACh receptors and the monoamine transporters.(In Vivo):Blonanserin (oral gavage; 1 mg/kg; 14 days) significantly ameliorates the social deficit observed in PCP-administered mice and inhibits the decrease in the levels of Ser897-phosphorylation, but preatment with blonanserin does not affect the social behaviors in saline-administered mice.
  • In Vitro
    Blonanserin exerts some blockade of?α1-adrenergic receptors?(Ki=26.7?nM) and also shows significant affinity for the?D3?receptor?(Ki=0.494 nM). Blonanserin possesses low affinity for the?sigma receptor?(IC50=286 nM), but lacks significant?affinity?for numerous other sites including the?5-HT1A,?5-HT3,?D1,?α2-adrenergic,?β-adrenergic,?H1, and?mACh receptors?and the?monoamine transporters.
  • In Vivo
    Blonanserin (oral gavage; 1 mg/kg; 14 days) significantly ameliorates the social deficit observed in PCP-administered mice and inhibits the decrease in the levels of Ser897-phosphorylation, but preatment with blonanserin does not affect the social behaviors in saline-administered mice. Animal Model:Mice received saline or phencyclidine once a day for 14 consecutive days Dosage:1 mg/kg Administration:Oral gavage; 1 mg/kg; 14 days Result:Had an effect on the social deficit in mice that received repeated PCP administration.
  • Synonyms
    AD5423 | Lonasen
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT2| D2
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    132810-10-7
  • Formula Weight
    367.5
  • Molecular Formula
    C23H30FN3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)
  • SMILES
    CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kawabe K, et al. Clin Neuropharmacol. 2013, Nov-Dec; 36(6):239-4
molnova catalog
related products
  • Lurasidone

    Lurasidone is an antagonist of both dopamine D2 and 5-HT7(IC50=1.68 and 0.495 nM, respectively).It also a partial agonist of 5-HT1A receptor(IC50 : 6.75 nM).

  • pCPA methyl ester hy...

    pCPA methyl ester hydrochloride is an inhibitor of tryptophan hydroxylase inhibitor and 5-HT synthesis. pCPA methyl ester hydrochloride is permeable across the blood-brain barrier and reduces 5-HT central availability.

  • BRL54443

    BRL54443 is a potent, releative selective 5-HT1E/1F agonist with Ki of 2/1 nM, respectively.